1. Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
   Marta Brunetti et al, 2022, Cancers CrossRef
2. Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?
   Erfaneh Barar et al, 2023, Biomedicines CrossRef
3. Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses
   Kun Fang et al, 2022, Frontiers in Pharmacology CrossRef
4. TLDc Domain-Containing Genes in Autism Spectrum Disorder: New Players in the Oxidative Stress Response
   Cinzia Zucchini et al, 2023, International Journal of Molecular Sciences CrossRef
5. Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies
   D. A. Trukhina et al, 2024, Problems of Endocrinology CrossRef
6. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
   Hyunho Kim et al, 2024, Clinical Orthopaedics & Related Research CrossRef
7. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling
   Liping Ying et al, 2023, Molecular Biology Reports CrossRef
8. DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling
   Hui Huang et al, 2022, Acta Biochimica et Biophysica Sinica CrossRef
9. LncRNA FEZF1-AS1 facilitates cisplatin resistance in non-small cell lung cancer through modulating the miR-32-5p-glutaminase axis
   Wei Lin, 2024, American Journal of Cancer Research CrossRef
10. Overexpression of miR-32 in Chinese hamster ovary cells increases production of Fc-fusion protein
    Masoume Bazaz et al, 2023, AMB Express CrossRef